Radiation therapy for recurrent clear cell ovarian carcinoma

被引：0
|
作者：
Westhoff, Gina [1 ]
Fuh, Katherine
Longacre, Teri [2 ]
McNally, Leah [3 ]
Hsu, Joe [4 ]
Kapp, Daniel S. [5 ]
Teng, Nelson [1 ]
Chen, Lee-May [4 ]
机构：
[1] Stanford Univ, Sch Med Gynecol Oncol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med Pathol, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med Obstet & Gynecol, Stanford, CA 94305 USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Stanford Univ, Sch Med Radiat Oncol, Stanford, CA 94305 USA
来源：
GYNECOLOGIC ONCOLOGY | 2013年 / 131卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2013.07.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：254 / 254
页数：1
相关论文
共 50 条
  • [31] Arginine deprivation as a potential targeted therapy for clear cell ovarian carcinoma.
    Xiao, Jennifer
    Ji, Ye
    Cochrane, Dawn R.
    Tessier-Cloutier, Basile
    Hoang, Lien N.
    Wang, Yikan
    Cheung, Angela
    Chow, Christine
    Colborne, Shane
    Hughes, Christopher
    Morin, Gregg B.
    Huntsman, David G.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 29 - 29
  • [32] Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
    Ackroyd, Sarah A.
    Arguello, David
    Ramos, Pilar
    Mahdi, Haider
    ElNaggar, Adam
    Winer, Ira
    Holloway, Rob
    Krivak, Thomas
    Jones, Nathaniel
    Turner, Valerie Galvan
    Herzog, Thomas
    Chu, Christina
    Brown, Jubilee
    Mantia-Smaldone, Gina
    GYNECOLOGIC ONCOLOGY, 2023, 169 : 164 - 171
  • [33] Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
    Mantia-Smaldone, G. M.
    Arguello, D.
    Mahdi, H.
    ElNaggar, A. C.
    Winer, I.
    Holloway, R. W.
    Krivak, T. C.
    Jones, N. L.
    Galvan-Turner, V.
    Herzog, T. J.
    Chu, C.
    Brown, J.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 175 - 175
  • [34] Ovarian clear cell carcinoma in Cowden Syndrome
    Yauy, K.
    Imbert-Bouteille, M.
    Bubien, V.
    Lindet-Bourgeois, C.
    Rathat, G.
    Perrochia, H.
    MacGrogan, G.
    Bessis, D.
    Tinat, J.
    Baert-Desurmont, S.
    Blanluet, M.
    Vande Perre, P.
    Baudry, K.
    Pujol, P.
    Corsini, C.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1558 - 1559
  • [35] Leiomyosarcoma with Synchronous Clear Cell Ovarian Carcinoma
    Rettenmaier, Mark
    Epstein, Howard D.
    Abaid, Lisa N.
    Bechtol, Karen A.
    Goldstein, Bram H.
    ONKOLOGIE, 2010, 33 (12): : 695 - 697
  • [36] Tumor heterogeneity in ovarian clear cell carcinoma
    Huang, Ruby Yun-Ju
    CANCER RESEARCH, 2024, 84 (05)
  • [37] Translational genomics of ovarian clear cell carcinoma
    Khalique, Saira
    Lord, Christopher J.
    Banerjee, Susana
    Natrajan, Rachael
    SEMINARS IN CANCER BIOLOGY, 2020, 61 : 121 - 131
  • [38] The unique metabolome of clear cell ovarian carcinoma
    Ji, Jennifer X.
    Hoang, Lien N.
    Cochrane, Dawn R.
    Lum, Amy
    Senz, Janine
    Farnell, David
    Tessier-Cloutier, Basile
    Huntsman, David G.
    Geltink, Ramon I. Klein
    JOURNAL OF PATHOLOGY, 2024, 264 (02): : 160 - 173
  • [39] Ovarian clear cell carcinoma - An examination of relapses
    Nguyen, P.
    Wong, F.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 225 - 226
  • [40] Napsin A as a marker of clear cell ovarian carcinoma
    Skirnisdottir, Ingiridur
    Bjersand, Kathrine
    Akerud, Helena
    Seidal, Tomas
    BMC CANCER, 2013, 13
12345